Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083549 · ClinicalTrials.gov registry record
Evaluating URMC's Massive Transfusion Protocol
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 2
- Enrollment target
NCT02083549 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 2 participants.
The verdict
NCT02083549 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of the University of Rochester Medical Center's current Massive Transfusion Protocol. Upon arrival of trauma level one designated patients the treating team evaluates the patient's injuries. If the patient is initiated under the facilities Massive Transfusion Protocol and meets other inclusion and exclusion criteria the patient will be enrolled in the study. Study procedures include collection of a blood sample following the transfusion of each shipment, through shipment 5, of blood products outlined in the current Massive Transfusion Protocol. Each blood sample will be run on a Thromboelastograph to evaluate the patient's hematostatic state through resuscitation. One final blood sample will be collected 24 hours following the discontinuation of the Massive Transfusion Protocol and also ran on the thromboelastograph. Due to the critical need for medical intervention, consent procedure will be waived at time of enrollment. An authorized representative for the patient will be identified and approached to obtain consent for use of data collected.
Interventions
- OTHER Blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-12-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02083549
The ClinicalTrials.gov registry entry for NCT02083549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood collection is the first listed.
NCT02083549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02083549 about?
NCT02083549 is a clinical study titled "Evaluating URMC's Massive Transfusion Protocol". The purpose of the study is to evaluate the efficacy of the University of Rochester Medical Center's current Massive Transfusion Protocol. Upon arrival of trauma level one designated patients the treating team evaluates the patient's injuries. If the patient is initiated under the facilities Massiv...
What is the current status of trial NCT02083549?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2014-12-16.
What interventions are being tested in trial NCT02083549?
The interventions under investigation include: Blood collection (OTHER).
Who is sponsoring clinical trial NCT02083549?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.